Literature DB >> 23349602

Olanzapine-induced electroencephalographic changes reversed by lamotrigine.

Prasuna L Velur1, Giridhar P Kalamangalam.   

Abstract

The atypical neuroleptic, olanzapine (OLZ), may induce electroencephalographic (EEG) abnormalities. The anticonvulsant, lamotrigine (LMG), reduces interictal epileptiform discharges and is effective in seizures in patients with both primary and partial epilepsy syndromes. The effect of LMG on neuroleptic-induced EEG abnormalities has not been previously reported. We describe the case of a 13-year-old male with paroxysmal nonepileptic spells who underwent diagnostic video-EEG telemetry, whose abnormal OLZ-induced EEG findings were strikingly affected by LTG withdrawal and reintroduction. The effect of LTG in normalizing EEG changes in suspected epilepsy caused by atypical neuroleptics is discussed.

Entities:  

Keywords:  Electroencephalographic; epilepsy; neuropsychiatry; psychopharmacology

Year:  2012        PMID: 23349602      PMCID: PMC3548375          DOI: 10.4103/0972-2327.104345

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


Introduction

Two modern atypical antipsychotics, olanzapine (OLZ) and clozapine, are associated with a high incidence of electroencephalographic (EEG) abnormalities,[1] such as slow waves, sharp discharges and sensitivity to hyperventilation. Some studies demonstrate a dose-related response.[2] The anticonvulsant lamotrigine (LMG) is effective in both primary and partial epilepsy syndromes, and has the effect of decreasing interictal epileptiform discharges.[3] LMG also has psychotropic activity and finds wide use in bipolar disorder. Here, we report a patient with OLZ-induced nonepileptiform EEG abnormalities that were strikingly affected by LMG withdrawal and reintroduction.

Case Report

A 13-year-old right-handed Caucasian boy underwent inpatient video-EEG telemetry for investigation of paroxysmal spells of inattention. Spells were of recent onset, and had only been observed at school. His mother related a tendency for him to become engrossed in reading, such that he would not respond to his name being called. She suspected that the spells observed at school were of a similarly benign nature. Nevertheless, due to a concern for nonconvulsive seizures, he was admitted for monitoring. Other medical history included bipolar disorder diagnosed at age 5 years, for which he received OLZ 15 mg/ day and LMG 200 mg/day. Physical examination revealed a well- looking, although reticent, child with no neurological findings. Brain magnetic resonance imaging at 3T was normal. Baseline awake and asleep EEG recording on Day 1 of hospitalization, while on his home medications, was normal. LMG was thereafter abruptly tapered to zero with the intent of inducing electrical epileptiform activity and/or paroxysmal clinical events. EEG in wakefulness from Day 2 onwards showed intermittent bursts of generalized slowing with frontal maximum that increased dramatically with hyperventilation [Figure 1]. Repeated bedside testing for attention, language, memory and motor function during hyperventilation-induced EEG changes was normal. No spontaneous pushbutton events were recorded. Photic stimulation produced a driving response only. The interictal sleep EEG was normal in all sleep stages. His mother reported some lability of mood during this time of LMG withdrawal. The drug was reinstituted on Day 5 at the original dose, resulting in a marked improvement in the EEG abnormalities [Figure 1] within 24 h, accompanying an immediate improvement in mood. He was discharged to outpatient psychiatric follow-up on Day 6, with a diagnosis of nonepileptic inattention and without medication changes being made.
Figure 1

Top panel: Electroencephalographic (EEG) changes of intermittent frontal-dominant high-amplitude slowing while on olanzapine following lamotrigine withdrawal. Longitudinal bipolar montage, 0.1–70 Hz passband, gain 7 μV/mm. Bottom panel: Exacerbation of EEG changes with hyperventilation. Repeated clinical testing of language, motor function and immediate memory was normal during such episodes

Top panel: Electroencephalographic (EEG) changes of intermittent frontal-dominant high-amplitude slowing while on olanzapine following lamotrigine withdrawal. Longitudinal bipolar montage, 0.1–70 Hz passband, gain 7 μV/mm. Bottom panel: Exacerbation of EEG changes with hyperventilation. Repeated clinical testing of language, motor function and immediate memory was normal during such episodes

Discussion

EEG abnormalities are relatively common (up to 38.5%) with OLZ therapy.[12] Abnormalities may comprise background slowing, sharp waves or paroxysmal slow waves, but not spike- or sharp-slow-wave complexes.[4] Quantitative EEG studies demonstrate increase in theta frequencies in the anterior cingulate and decrease in alfa and beta frequencies in the occipital cortex and posterior limbic structures.[5] LMG affects the neural generators of epileptiform EEG, causing normalization of the background spectrum in addition to decreasing interictal spiking.[6-8] The drug has multiple mechanisms of action and decreases theta activity in several cortical areas.[3] Our patient developed abundant interictal abnormalities that were confirmed nonepileptiform on withdrawal of LMG, and were typical of those induced by OLZ. The effect of LMG withdrawal on unmasking the OLZ-related EEG abnormalities, and the immediate improvement on reinstituting LMG, argued for a direct role of LMG in modifying the OLZ-related EEG response. We suggest that LMG may have acted in our patient by modulating the theta frequency changes[3] induced by OLZ.[5] More generally, this case emphasizes the profound EEG effects of a commonly used neuroleptic. In the setting of suspected epilepsy, such EEG changes may serve as significant confounds; diagnostic uncertainty is further perpetrated by the action of anticonvulsants on the EEG changes. As always, the diagnosis of epilepsy remains a clinical one, resting on the judicious interpretation of the EEG in the light of the history and physical findings.
  8 in total

1.  Lamotrigine decreases EEG synchronization in a use-dependent manner in patients with idiopathic generalized epilepsy.

Authors:  B Clemens; P Piros; M Bessenyei; K Hollódy
Journal:  Clin Neurophysiol       Date:  2007-01-26       Impact factor: 3.708

2.  Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment.

Authors:  Adam Wichniak; Tomasz Szafranski; Aleksandra Wierzbicka; Elzbieta Waliniowska; Wojciech Jernajczyk
Journal:  J Psychopharmacol       Date:  2005-10-04       Impact factor: 4.153

3.  The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy.

Authors:  A S Eriksson; E Knutsson; A Nergårdh
Journal:  Epilepsia       Date:  2001-02       Impact factor: 5.864

4.  Electroencephalogram alterations during treatment with olanzapine.

Authors:  F Pillmann; K Schlote; K Broich; A Marneros
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

5.  Antiepileptic drugs modify power of high EEG frequencies and their neural generators.

Authors:  S Arzy; G Allali; D Brunet; C M Michel; P W Kaplan; M Seeck
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

6.  EEG abnormalities during treatment with typical and atypical antipsychotics.

Authors:  Franca Centorrino; Bruce H Price; Margaret Tuttle; Won-Myong Bahk; John Hennen; Matthew J Albert; Ross J Baldessarini
Journal:  Am J Psychiatry       Date:  2002-01       Impact factor: 18.112

7.  LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia.

Authors:  Barbora Tislerova; Martin Brunovsky; Jiri Horacek; Tomas Novak; Miloslav Kopecek; Pavel Mohr; Vladimír Krajca
Journal:  Neuropsychobiology       Date:  2008-09-10       Impact factor: 2.328

8.  Imaging the cortical effect of lamotrigine in patients with idiopathic generalized epilepsy: a low-resolution electromagnetic tomography (LORETA) study.

Authors:  Béla Clemens; Pálma Piros; Mónika Bessenyei; Márton Tóth; Katalin Hollódy; István Kondákor
Journal:  Epilepsy Res       Date:  2008-07-23       Impact factor: 3.045

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.